Skip to main content
Richard Lin, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

RichardJiruiLinMDPhD

Oncology New York, NY

Hematologic Oncology, Hospice & Palliative

Assistant Member, Hematopoietic Stem Cell Transplantation, Cellular Therapy, Memorial Sloan Kettering Cancer Center

Overview of Dr. Lin

As a hematopoietic cell transplant/cell therapy clinician, I aim to deliver the best possible care for all patients with advanced hematologic malignancies through my clinical expertise, multidisciplinary team care, and state of art therapeutics and clinical trials. As a clinical investigator, I strive to stay at the academic intersection of hematologic malignancy, transplantation, cellular therapy, and geriatrics/supportive care to improve outcomes for vulnerable older patients, and to identify translational targets in aging pathways for mechanism-based therapy in hematologic malignancies. https://www.mskcc.org/cancer-care/doctors/richard-lin

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Blood & Bone Marrow Transplant, 2017 - 2019
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2014 - 2017
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 2006 - 2009
  • Harvard Medical School
    Harvard Medical SchoolClass of 2006, MD
  • University of California San Diego
    University of California San DiegoPhD, Molecular Biology, 1995 - 2001
  • Nankai University
    Nankai UniversityBS, Biochemistry, 1990 - 1994

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • NY State Medical License
    NY State Medical License 2009 - 2024
  • PA State Medical License
    PA State Medical License 2023 - 2024
  • CT State Medical License
    CT State Medical License 2023 - 2024
  • IL State Medical License
    IL State Medical License 2006 - 2009
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Hospice and Palliative Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Conquer Cancer Foundation of ASCO Merit Award ASCO, 2017
  • Chief Fellow in Hematology Oncology New York University School of Medicine, 2016
  • Future Leaders in Hematology Award Celgene Foundation, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation
    Richard J Lin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple Myeloma
    Richard J Lin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A...
    Richard J Lin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Impact of geriatric vulnerability on outcomes of older patients in allogeneic hematopoietic cell transplantation. 
    2019 ASCO Annual Meeting - 6/1/2019
  • A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Authored Content

  • T-Cell Stemness, Aging, and Cancer ImmunotherapyJanuary 2020
  • Bone Marrow Transplants and Older Adults: 3 Important QuestionsAugust 2018

Press Mentions

  • Older Adults with Newly Diagnosed AML: Hot Topics for the Practicing Clinician
    Older Adults with Newly Diagnosed AML: Hot Topics for the Practicing ClinicianMay 1st, 2023

Professional Memberships

Other Languages

  • Chinese (Mandarin)

Hospital Affiliations